Rephonic
Artwork for OncLive® On Air

OncLive® On Air

OncLive® On Air
Non-Small Cell Lung Cancer
Immunotherapy
Breast Cancer
Small Cell Lung Cancer
Clinical Trials
Multiple Myeloma
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Triple Negative Breast Cancer
Oncology
Pembrolizumab
Antibody Drug Conjugates
Hr-Positive Her2-Negative Metastatic Breast Cancer
Biomarker Testing
Prostate Cancer
Chemotherapy
BTK Inhibitors
KRAS
PARP Inhibitors
ESR1 Mutations

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers,... more

PublishesDailyEpisodes500Founded8 years ago
Number of ListenersCategories
Health & FitnessScience

Listen to this Podcast

Artwork for OncLive® On Air

Latest Episodes

In today’s episode, we welcomed Ruben Mesa, MD, FACP, who outlined the significance of the August 2026 FDA approval of ropeginterferon alfa-2b-njft (Besremi) for the treatment of adult patients with essential thrombocythemia. Dr Mesa is senior vice p... more

In today’s episode, we spoke with Kim A. Reiss Binder, MD, about the August 2026 FDA approval of daraxonrasib (Rasonque) for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least 1 prior systemic therapy... more

In this episode, we spoke with Arndt Vogel, MD, a faculty member at the University of Toronto Institute of Medical Science, a scientist at the Toronto General Hospital Research Institute, and a medical oncologist at the UHN–Princess Margaret Cancer C... more

In this episode, produced in coordination with Oncology Nursing News®, Beth Faiman, PhD, MSN, APN-BC, AOCN, FAAN, FAPO, and Sikander Ailawadhi, MD, discussed evolving administration strategies for multiple myeloma therapies, primarily focusing on sub... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Recent Guests

Kim A. Reiss Binder
MD, discussed as the expert guest
University/Institution not specified in transcript
Episode: S19 Ep2: FDA Approval Insights: Daraxonrasib for Metastatic Pancreatic Ductal Adenocarcinoma
Arndt Vogel
MD, expert in FGFR inhibitors for cholangiocarcinoma
Episode: S19 Ep2: Resistance Patterns Shape FGFR Inhibitor Sequencing in Cholangiocarcinoma
Beth Faiman
Advanced Practice Provider and Researcher
Cleveland Clinic
Episode: S19 Ep1: Subcutaneous Therapies Bolster Administration Options in Multiple Myeloma
Sikander Ailawadhi
Professor of Medicine and Chair of the Myeloma and Dysprotonemia Disease Group
Mayo Clinic
Episode: S19 Ep1: Subcutaneous Therapies Bolster Administration Options in Multiple Myeloma
Jacqueline Aredo
Thoracic oncologist
Mass General Brigham Cancer Institute
Episode: S18 Ep49: Start Earlier and Find Your Community: Navigating the Fellowship-to-Faculty Transition Through Mentorship and Specialty-Focused Meetings
Benjamin Bleiberg
Adjunct assistant professor of medicine
University of Pennsylvania Perelman School of Medicine
Episode: S18 Ep49: Start Earlier and Find Your Community: Navigating the Fellowship-to-Faculty Transition Through Mentorship and Specialty-Focused Meetings
Angela Waanders
Dr. Waanders discussed case-based imaging and molecular testing in glioma
Episode: S18 Ep48: OncoBytes Adaptive Learning Pathways™: Decoding Precision Diagnostics and Targeted Therapies in Glioma
Vinay Puduvalli
Episode: S18 Ep48: OncoBytes Adaptive Learning Pathways™: Decoding Precision Diagnostics and Targeted Therapies in Glioma
Ruham Nasany
Episode: S18 Ep48: OncoBytes Adaptive Learning Pathways™: Decoding Precision Diagnostics and Targeted Therapies in Glioma

Reviews

4.5 out of 5 stars from 33 ratings
  • Best option for CME podcasts

    Love the content! Easily the best platform for listening to CME and staying updated while on the go. Keep up the great work!

    Apple Podcasts
    5
    Dlshaka
    United Statesa year ago
  • My favorite podcast for oncology

    This podcast provides excellent information to anyone who works in the medical field on oncology.

    Apple Podcasts
    5
    Chiliman1986
    United States7 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners value data-driven discussion and expert guest diversity.
Great CME content for clinicians and researchers.
High-quality oncology insights and practical takeaways.

Top Health & Fitness Podcasts

Talking Points

Recent interactions between the hosts and their guests.

S18 Ep50: Navigating DLL3-Targeting T-Cell Engagers and the Evolving Small Cell Lung Cancer Treatment Landscape
Q: Is DLL-3 testing necessary for treatment decisions, and how might testing turnaround affect practice?
There is debate about the necessity of DLL-3 testing for all patients, but rapid, accessible testing could help tailor therapy; however, delays in testing could hinder timely treatment initiation in practice.
S18 Ep50: Navigating DLL3-Targeting T-Cell Engagers and the Evolving Small Cell Lung Cancer Treatment Landscape
Q: What are the key toxicity concerns with DLL-3–engagers that could affect their place in therapy?
CRS and ICANS are the main toxicity considerations; worse toxicity could limit earlier use, and ongoing data are needed to understand how safety profiles compare across induction, maintenance, and relapse settings.
S18 Ep50: Navigating DLL3-Targeting T-Cell Engagers and the Evolving Small Cell Lung Cancer Treatment Landscape
Q: What is Delphi 305 showing in terms of survival benefit, and how might it change first-line maintenance decisions?
Delphi 305 has the potential to reshape both front-line maintenance and later-line settings, but adoption will depend on demonstrating a clear survival advantage and manageable toxicity compared with current maintenance options.
S18 Ep47: Dissecting Diagnostic and Management Factors in Systemic Mastocytosis
Q: Looking to the future, are there any unmet needs that still need to be addressed for patients with non-advanced systemic mastocytosis?
Unmet needs include understanding how improvements in bone mineral density translate to reductions in fragility fractures, clarifying the impact on rare events like anaphylaxis, and determining whether therapies can prevent progression or allow safe treatment interruptions for life events, all requiring longer-term studies.
S18 Ep47: Dissecting Diagnostic and Management Factors in Systemic Mastocytosis
Q: How do you differentiate between advanced versus non-advanced systemic mastocytosis during the diagnostic process, and what features do you look out for?
Differentiation hinges on meeting the diagnostic criteria (major plus minor or at least three minors) and then identifying features of advanced disease such as mast cell leukemia criteria, C findings like organ damage (cytopenias, hepatosplenomegaly, weight loss with GI involvement), and the presence of associated hematologic neoplasms; the assessment is integrated with clinical and laboratory data.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About OncLive® On Air

What is OncLive® On Air about and what kind of topics does it cover?

A biomedical-focused interview series features in-depth conversations with academic oncologists and physician-recholers who dissect cutting-edge oncology data, trials, and therapeutic strategies. Topics span targeted therapies, antibody-drug conjugates, immunotherapy combinations, precision oncology, and novel delivery methods across solid tumors and hematologic malignancies. Episodes emphasize practical takeaways for clinical practice, real-world constraints, biomarker-driven decision-making, and the evolving treatment landscape presented at major conferences. A standout pattern is how guests translate complex trial results into actionable insights for clinicians, with recurring attention to safety signals, sequencing, patient quality of l... more

Where can I find podcast stats for OncLive® On Air?

Rephonic provides a wide range of podcast stats for OncLive® On Air. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to OncLive® On Air and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does OncLive® On Air get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for OncLive® On Air, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for OncLive® On Air?

Rephonic provides comprehensive predictive audience data for OncLive® On Air, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does OncLive® On Air have?

To see how many followers or subscribers OncLive® On Air has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

How many episodes of OncLive® On Air are there?

OncLive® On Air launched 8 years ago and published 500 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact OncLive® On Air?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for OncLive® On Air?

Rephonic pulls ratings and reviews for OncLive® On Air from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for OncLive® On Air?

Rephonic provides full transcripts for episodes of OncLive® On Air. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on OncLive® On Air?

Recent guests on OncLive® On Air include:

1. Kim A. Reiss Binder
2. Arndt Vogel
3. Beth Faiman
4. Sikander Ailawadhi
5. Jacqueline Aredo
6. Benjamin Bleiberg
7. Angela Waanders
8. Vinay Puduvalli

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days